Complete Genomics Company Profile (NASDAQ:GNOM)

About Complete Genomics (NASDAQ:GNOM)

Complete Genomics logoComplete Genomics, Inc. is a life sciences company that has developed and commercialized a deoxyribonucleic acid (DNA) sequencing platform. Its complete genomics analysis platform (CGA) Platform, combines its human genome sequencing technology with its advanced informatics and data management software and its end-to-end, outsourced service model to provide its customers with data that is ready to be used for genome-based research. Its genome sequencing center combines a high-throughput sample preparation facility, a collection of its high-throughput sequencing instruments and a large- scale data center. Its customers include some of the global academic and government research centers and biopharmaceutical companies. Effective March 18, 2013, BGI-Shenzhen announced that through its wholly-owned subsidiary, Beta Acquisition Corporation, it has completed the acquisition of the Company.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:GNOM
  • CUSIP: N/A
  • Web: N/A
  • Trailing P/E Ratio:
  • P/E Growth:
  • Dividend Yield: 1.0%
Frequently Asked Questions for Complete Genomics (NASDAQ:GNOM)

What is Complete Genomics' stock symbol?

Complete Genomics trades on the NASDAQ under the ticker symbol "GNOM."

Who are some of Complete Genomics' key competitors?

How do I buy Complete Genomics stock?

Shares of Complete Genomics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Complete Genomics' stock price today?

One share of Complete Genomics stock can currently be purchased for approximately $3.14.

MarketBeat Community Rating for Complete Genomics (NASDAQ GNOM)
Community Ranking:  2.5 out of 5 (  )
Outperform Votes:  28 (Vote Outperform)
Underperform Votes:  29 (Vote Underperform)
Total Votes:  57
MarketBeat's community ratings are surveys of what our community members think about Complete Genomics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Complete Genomics (NASDAQ:GNOM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Complete Genomics (NASDAQ:GNOM)
No equities research coverage for this company has been tracked by


Earnings History for Complete Genomics (NASDAQ:GNOM)
Earnings by Quarter for Complete Genomics (NASDAQ:GNOM)
Earnings History by Quarter for Complete Genomics (NASDAQ GNOM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2012Q312($0.52)($0.52)$8.05 million$7.27 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Complete Genomics (NASDAQ:GNOM)

No earnings estimates for this company have been tracked by


Dividend History for Complete Genomics (NASDAQ:GNOM)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Complete Genomics (NASDAQ:GNOM)
No insider trades for this company have been tracked by


Headline Trends for Complete Genomics (NASDAQ:GNOM)
Latest Headlines for Complete Genomics (NASDAQ:GNOM)
No headlines for this company have been tracked by



Complete Genomics (GNOM) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by Staff